16.05.2023 - 18.05.2023Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 am - 4:00 pm
Temi della conferenza Following the excitement behind President Biden signing the FDA modernization Act 2.0 in December 2022, Hesperos and Sanofi successfully getting IND approval from organ-on-chip data for a Phase2 clinical trial, and NIH bioprinting eye tissue to develop in vitro models of AMD, the , the 8th Annual 3D Tissue Models Summit will return to Boston in May 2023 to reunite the community of drug discovery and development experts.